Press Releases

• • •

• • •

Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025

Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 Mont-Saint-Guibert, Belgium – Wednesday May 7, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for

• • • Read More • • •

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr.

• • • Read More • • •

­­­­Vingroup and the Rise of the ESG Ecosystem

Vingroup is positioning itself to lead Vietnam’s ESG push, using its broad business network to drive sustainable growth at home and abroad, while eyeing partnerships in the Middle East’s expanding sustainability sector. HANOI, VIETNAM – Media OutReach Newswire – 7 May 2025 – In one of Vietnam’s crowded conference halls this month, corporate

• • • Read More • • •

RECENT POSTS